AstraZeneca is a leading global pharmaceutical company with strong growth in oncology, diversified revenues, and a robust ...
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer ...
Explore how idiopathic pulmonary fibrosis could be a key model for testing ageing drugs and addressing age-related diseases.
News-Medical.Net on MSN
Deep learning tool improves accuracy of lung nodule malignancy detection
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results.
Video-assisted thoracoscopic surgery demonstrated superior overall survival than open lobectomy in patients with early-stage lung cancer.
Fibrosis of the lungs is often a silent disease until it's too late. By the time patients are diagnosed, the scarring of ...
News-Medical.Net on MSN
AI toolset reveals links between lung fibrosis and aging
A new research paper was published in Volume 17, Issue 8 of Aging-US on August 8, 2025, titled "AI-driven toolset for IPF and ...
OXFORD, United Kingdom and HOUSTON, Aug. 26, 2025 /PRNewswire/ -- Optellum, a global leader in AI for lung health, today announced the world's first thorax CT foundation model built for precision lung ...
Rein recently announced regulatory approval from the U.K.’s MHRA to initiate the Phase 2 RENEW trial of LTI-03. The trial will evaluate safety, tolerability, and changes in lung function in up to 120 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback